DeuteRx CEO Honored with Two Industry Awards for Entrepreneurial Success and Innovation in Biopharma R&D
Hand-out
Press Releases
DeuteRx LLC  
April 23, 2025

DeuteRx CEO Honored with Two Industry Awards for Entrepreneurial Success and Innovation in Biopharma R&D

Lead preclinical program, DRX-184 (d-S-bupropion), granted new US patent with term to May 2044.

avatar profile Olean Times Herald

Olean Times Herald


Local & Social